NTRK1 and neoplasm: Initially defined as regulators of neuronal development and nerve–tumor interactions, neural mediators including neurotrophins and their receptors are now recognized as drivers of tumor progression, host immunity and, via oncogenic Trk fusions, cancer therapy.